Next Article in Journal
Eyelash Trichomegaly Secondary to Panitumumab Therapy
Previous Article in Journal
Managing Treatment-Related Adverse Events Associated with egfr Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 18
Issue 3
10.3747/co.v18i3.857
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Meeting Report

Canadian Initiatives for Locally Advanced Breast Cancer Research and Treatment: Inaugural Meeting of the Canadian Consortium for LABC

by
M. Brackstone
1,2,*,
A. Robidoux
3,
S. Chia
4,
J. Mackey
5,
R. Dent
6,
J.F. Boileau
6 and
M. Clemons
7
1
London Health Sciences Center, London, ON, Canada
2
London Regional Cancer Program, Division of General Surgery/Surgical Oncology, 790 Commissioners Road E, Room A3-931, London, ON N6A 4L6, Canada
3
University of Montreal, Montreal, QC, Canada
4
BC Cancer Agency, Vancouver, BC, Canada
5
Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
6
Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
7
The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(3), 139-144; https://doi.org/10.3747/co.v18i3.857
Submission received: 4 March 2011 / Revised: 3 April 2011 / Accepted: 2 May 2011 / Published: 1 June 2011

Abstract

The inaugural Canadian Consortium for LABC (locally advanced breast cancer) conference was held at Langdon Hall, Cambridge, Ontario, April 11–12, 2010. The meeting focused on current and future directions in labc treatment and research, the specific benefits of labc as a model for clinical and translational research, strategies for increased national and international collaboration, and ongoing clinical trials. Exciting Canadian initiatives in labc research are underway, focusing on identifying molecular signatures that will allow for the development of new tailored therapies. The challenge of identifying patient subgroups for accrual is being addressed through strategies to foster and improve national collaboration. This meeting report includes highlights from each presentation at the conference.
Keywords: breast neoplasms; cancer treatment; clinical research; translational research; neoadjuvant therapy; biomarkers breast neoplasms; cancer treatment; clinical research; translational research; neoadjuvant therapy; biomarkers

Share and Cite

MDPI and ACS Style

Brackstone, M.; Robidoux, A.; Chia, S.; Mackey, J.; Dent, R.; Boileau, J.F.; Clemons, M. Canadian Initiatives for Locally Advanced Breast Cancer Research and Treatment: Inaugural Meeting of the Canadian Consortium for LABC. Curr. Oncol. 2011, 18, 139-144. https://doi.org/10.3747/co.v18i3.857

AMA Style

Brackstone M, Robidoux A, Chia S, Mackey J, Dent R, Boileau JF, Clemons M. Canadian Initiatives for Locally Advanced Breast Cancer Research and Treatment: Inaugural Meeting of the Canadian Consortium for LABC. Current Oncology. 2011; 18(3):139-144. https://doi.org/10.3747/co.v18i3.857

Chicago/Turabian Style

Brackstone, M., A. Robidoux, S. Chia, J. Mackey, R. Dent, J.F. Boileau, and M. Clemons. 2011. "Canadian Initiatives for Locally Advanced Breast Cancer Research and Treatment: Inaugural Meeting of the Canadian Consortium for LABC" Current Oncology 18, no. 3: 139-144. https://doi.org/10.3747/co.v18i3.857

Article Metrics

Back to TopTop